- Home
- Medical
- Cardiology
- New Therapeutic Agents in Thrombosis and Thrombolysis
New Therapeutic Agents in Thrombosis and Thrombolysis
List Price:
$76.99
- Availability: Confirm prior to ordering
- Branding: minimum 50 pieces (add’l costs below)
- Check Freight Rates (branded products only)
Branding Options (v), Availability & Lead Times
- 1-Color Imprint: $2.00 ea.
- Promo-Page Insert: $2.50 ea. (full-color printed, single-sided page)
- Belly-Band Wrap: $2.50 ea. (full-color printed)
- Set-Up Charge: $45 per decoration
- Availability: Product availability changes daily, so please confirm your quantity is available prior to placing an order.
- Branded Products: allow 10 business days from proof approval for production. Branding options may be limited or unavailable based on product design or cover artwork.
- Unbranded Products: allow 3-5 business days for shipping. All Unbranded items receive FREE ground shipping in the US. Inquire for international shipping.
- RETURNS/CANCELLATIONS: All orders, branded or unbranded, are NON-CANCELLABLE and NON-RETURNABLE once a purchase order has been received.
Product Details
Author:
Jane E. Freedman, Joseph Loscalzo
Format:
Hardcover
Pages:
712
Publisher:
CRC Press (June 24, 2009)
Language:
English
Audience:
Professional and scholarly
ISBN-13:
9781420069235
Weight:
48oz
Dimensions:
7" x 10"
File:
TAYLORFRANCIS-TayFran_260415045630016-20260415.xml
Folder:
TAYLORFRANCIS
List Price:
$76.99
Country of Origin:
United States
Case Pack:
10
As low as:
$73.14
Publisher Identifier:
P-CRC
Discount Code:
H
Pub Discount:
30
Imprint:
CRC Press
Overview
As the number of patients with thrombosis and thrombolysis increases, there is a critical need for clinicians to learn the latest scientific discoveries and treatment options. This timely Third Edition is a comprehensive text for cardiologists, hematologists, and pharmacologists in need of a resource on current agent development technology for treating cardiovascular and thromboembolic diseases.
New to the Third Edition:
- a thorough examination of all the agents involved in treating thrombosis
- chapters on biomarkers, testing, and pharmacogenomics
- key topics, including new targets for antithrombotics, the development of novel classes of platelet inhibitors, new thrombolytic therapies, and evolving clinical uses of thrombolytics for ischemic stroke and venous thrombosis
- the hemostatic and thrombotic pathways
